Mohnish Pabrai, one of our favourite stock wizards, has suffered a crippling loss of Rs. 400 crore ($62M) as one of his concentrated bets has gone horribly wrong. Thankfully, Mohnish is taking the loss in his stride and is instead explaining the lessons that he has learnt from the fiasco
After Shankar Sharma’s clarion call that small-cap stocks will give up to 300% gains in the next three years, the onus is on us to identify these stocks. Luckily, seven top-quality small-cap stocks have been handed over to us on a platter by ET
Shankar Sharma has sent the clarion call that novice investors should stop fussing with large-cap stocks and should instead focus on top-quality micro, small and mid-cap stocks if they want to make a fortune
A micro-cap stock which has won the confidence of Dolly Khanna and which has also been certified as a “game changer” by Daljeet Kohli has the potential to give 100% gains is the confident prediction of East India Securities
Saurabh Mukherjea’s prediction that the Sensex would crash to a low of 22,000 had caused panic amongst novice investors and many dumped their stocks. Now that he has done a somersault, investors are feeling short-changed and are ruing the loss of mega bucks that would have otherwise effortlessly come into their pockets due to the raging rally
Rakesh Jhunjhunwala watches his favourite stocks like a hawk. He knows every little nuance in the accounts and demands answers to tough questions from the management. We need to learn from him and get our own act in order
A small-cap specialty chemicals stock with powerhouse credentials and which was one of the favourites of Jwalamukhi/ Westbridge Capital has come back into the reckoning with several leading experts recommending a buy
Billionaire stock investors are supposed to have an instinct for sniffing out undervalued stocks with the potential for hefty gains. The fact that the duo of Rakesh Jhunjhunwala & MA Yusuffali has invested large sums in a mid-cap bank implies that mega gains are in the offing for the lucky shareholders of the Bank
Daljeet Kohli is known to be a master of Pharma stocks while Porinju Veliyath is lauded for his expertise in harvesting mega gains from underdog stocks. Both have homed in on a mid-cap Pharma stock but expressed contrary views about its future prospects
A mid-cap bank which was earlier touted as a potential “100-bagger” stock by the cognoscenti and which subsequently fell from grace owing to its “dangerous, unexpected and disappointing shift” in strategy has come back into the reckoning owing to the damage control measures implemented by its management
Recent Comments